Sai Parenterals Ltd Financials
Company Logo

Sai Parenterals Ltd Financial Statement

Sai Parenterals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Sai Parenterals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual124.27
Operating Expenses Annual97.30
Operating Profit Annual27.19
Interest Annual7.31
Depreciation5.49
Net Profit Annual10.34
Tax Annual4.05

Sai Parenterals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning1.38
Cash Flow from Operations9.80
Cash Flow from Investing-4.27
Cash Flow from Financing-5.81
Cash Flow at the End1.10

Sai Parenterals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)21.88
PBIT Margin (%)17.46
PBT Margin (%)15.07
Net PROFIT Margin (%)8.32
Return On Networth / Equity (%)12.21
Return On Networth /Employed (%)13.87
Return On Assets (%)6.57
Total Debt / Equity (X)0.84
Asset Turnover Ratio (%)0.79

Sai Parenterals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual39.90
Total Current Assets Annual132.41
Non Current Assets Annual82.74
Total Shareholders Funds Annual91.34
Total Assets Annual215.15

Sai Parenterals Ltd Earning Calls

No Data Availabe

FAQS on Sai Parenterals Ltd Financials

As of Apr 4, 2026, Sai Parenterals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Sai Parenterals Ltd is not with a debt-to-equity ratio of 0.79.

In FY 2025 , Sai Parenterals Ltd recorded a total revenue of approximately 124.27 Cr marking a significant milestone in the company's financial performance.

Sai Parenterals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.1% annually, respectively..

Sai Parenterals Ltd's current PE ratio is .

Sai Parenterals Ltd's ROCE averaged 12.1% from the FY ending March 2023 to 2025, with a median of 12.1%. It peaked at 13.3% in March 2025, reflecting strong capital efficiency over the period..

Sai Parenterals Ltd's latest EBIT is Rs. 21.70 Cr, surpassing the average EBIT of Rs. 16.72 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions